. . . . . . . . . . . . . "p(HGNC:CCR2) -> p(HGNC:MAPK1)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "Treatment of fibroblast-like synoviocyte (FLS) cultures with RS-504393, a CCR-2 antagonist significantly inhibited the CCL-2 induced ERK-2 activation, indicating that CCL-2 induced ERK-2 activation was mediated by CCR-2." . . "Selventa" . . . . "2014-07-03T14:29:58.778+02:00"^^ . . .